Lv3
360 积分 2023-04-03 加入
Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients
4个月前
已完结
LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study
4个月前
已完结
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
4个月前
已完结
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
4个月前
已完结
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
4个月前
已完结
Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis
4个月前
已完结
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
4个月前
已完结
Effect of bariatric surgery on cancer risk: results from an emulated target trial using population-based data
5个月前
已完结
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity
5个月前
已完结
皖公网安备34019202002308
